http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4017859-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b906ce2a05823a4b88b1cee1aef079d6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2c09d1217445221f86e226b3b226656 |
| publicationDate | 2022-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-4017859-A1 |
| titleOfInvention | Alkyl quarternary ammonium tryptamines and their therapeutic uses |
| abstract | The invention relates to a compound of formula (I): The invention also relates to crystalline compounds of formula (I). The invention relates to compositions comprising, consisting essentially of, or consisting of a compound of formula (I) and an excipient. The invention also relates to pharmaceutical compositions comprising a therapeutically effective amount of a compound of formula (I) where the excipient is a pharmaceutically acceptable carrier. The invention further relates to therapeutic uses of compounds of formula (I). |
| priorityDate | 2019-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 390.